JACKSONVILLE, Fla., Aug. 01, 2017 -- Stein Mart, Inc. (NASDAQ:SMRT) plans to release its second quarter 2017 financial results after the U.S. financial markets close on Wednesday, August 16, 2017. At 4:30 p.m. ET that day, management will hold a conference call to discuss results and operations. The call will be hosted by Stein Mart’s chief executive officer, Hunt Hawkins; president, MaryAnne Morin; and chief financial officer, Greg Kleffner.
If you would like to participate in the conference call, the U.S. toll free dial-in is 1-877-705-6003 and the international dial-in number is 1-201-493-6725. A live webcast of the conference call will also be available on the company’s investor relations website at http://ir.steinmart.com. A replay of the call will be available on the website through August 31, 2017.
About Stein Mart
Stein Mart, Inc. is a national specialty and off-price retailer offering designer and name-brand fashion apparel, home décor, accessories and shoes at everyday discount prices. Stein Mart provides real value that customers will love every day both in stores and online. The Company currently operates 292 stores across 31 states. For more information, please visit www.steinmart.com.
For more information: Linda L. Tasseff Director, Investor Relations (904) 858-2639 [email protected]


Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Italy Fines Apple €98.6 Million Over App Store Dominance
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 



